Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata available, this FDA Warning Letter issued in May 2024 concerns Toltrazuril Shop, a company involved in veterinary products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be precisely determined from the metadata alone. The warning falls under FDA's veterinary product regulatory scope, though the specific issuing office is not identified in the available information. Additional details would be needed to characterize the particular compliance concerns that prompted this enforcement action.